Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis

Completed · Phase 3

Conditions studied: Herpes Labialis

In brief

The purpose of this study is to determine whether ME-609 is more efficient than acyclovir and placebo for the treatment of recurrent herpes labialis.

Key facts

Study ID

NCT00361881

Run by

Medivir

People needed

1443

Starts

2006-07-01

Expected to finish

2007-12-01

Last updated by the study team

2008-08-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Generally good health
• History of recurrent herpes labialis with at last three episodes during the prior 12 months

You may not qualify if…

• Treatment with antivirals or immunosuppressive agents within 2 weeks prior to randomization
• Pregnant and/or nursing women
• Continuous daily treatment with pain medication
• Significant skin condition that occur in the area of herpes recurrences

Where it is running

• Coastal Caroline Research Center — Mt. Pleasant, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.